Trial Profile
Efficacy and safety of ipilimumab in patients with previously treated advanced melanoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 28 Jun 2016 New trial record